HCRT and depressive disorder: The use of benzodiazepines or dopamine agonists, nocturnal sleep disorders, changes in the sleep/wake cycle; decreased orexin levels, autonomic dysfunction, and depression have been reported as risk factors for EDS (43, 47, 48).